Home Tags Lonza

lonza

Lonza Celebrates BBB+ Rating by S&P

Basel, Switzerland--Lonza, a supplier to the pharmaceutical, biotech and specialty ingredients markets, announced that it has received a S&P BBB+ rating.

Neptune Wellness Solutions Receives License to Process Cannabis

Laval, Québec—Neptune Wellness Solutions announced in a press release that it has received its license to process cannabis from Health Canada. The Health Canada license...

Lonza Consumer Health and Nutrition Joins Clean Label Alliance

Greenwood, SC -- Lonza announced its Consumer Health & Nutrition team will become a founding member of the Clean Label Alliance, an initiative aimed at...

Lonza Adds Color to the Clean-Label Experience

Greenwood, SC -- Supplement manufacturers can now choose from a range of clean-label colorants when selecting Lonza Capsugel Vcaps Plus plant-based capsules, following the launch...

Lonza Reports Positive Start to 2018

Basel, Switzerland — Lonza reported a positive start, led by its contingent of healthcare businesses, during its quarterly earnings call. The former Capsugel business, now...

Lonza Opens Next Gen Cell-and-Gene-Therapy Manufacturing Facility

Pearland, TX – Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, built in anticipation of rising demand from developers of cell and gene...

Prolog Partners with Lonza to Invest in Wellness Startups

Basel, Switzerland - Swiss pharmaceutical and biotech firm Lonza is partnering with U.S.-based Prolog Ventures to create a venture capital fund focusing on consumer health...
Capsugel Lonza

Lonza’s Capsugel Integration on Track

Basel, Switzerland – Lonza’s integration of Capsugel is on track as the company forecasts combined high single-digit sales growth for the year. The first...

Lonza Reports Strong First Half Results

Basel, Switzerland – Lonza reported a strong growth path for the first half of 2017, with sales up 15.1% to CHF 2,323 million compared...

Lonza Closes Capsugel $5.5 Billion Purchase

Basel, Switzerland – Lonza announced today it has completed the acquisition of Capsugel S.A. from KKR for $5.5 billion in cash, including refinancing of...

BACK ISSUES

MULTIMEDIA